The Supreme Court ruled that NEET UG qualification is mandatory for Indian students seeking to study MBBS abroad if they intend to practice in India. The court dismissed petitions challenging the requirement, upholding its necessity. It emphasized that the rule ensures uniform standards for medical education. Additionally, the bench refused to grant any one-time exemption.
The Supreme Court today rejected a plea to postpone the NEET-PG 2024 exam scheduled for August 11, emphasizing the risk to two lakh students’ futures. The plea cited difficulties in reaching exam cities and undisclosed normalization formulas. Another petition submitted similar concerns. The court stressed the impact on numerous candidates and their families.
The CBI arrested a first-year MBBS student from RIMS Ranchi and four medical students from AIIMS Patna in connection with the NEET-UG paper leak case. Furthermore, two more individuals were detained. The NEET-UG exam faced cheating allegations, leading to protests and legal actions, prompting the postponement of the NEET-PG 2024 examination.
Today, On 14th June, The Supreme Court called for a response from the Central Government and the National Testing Agency regarding a plea for a CBI investigation into alleged irregularities in the NEET-UG exam. The requests follow concerns about potential misconduct and errors in the examination process, including question paper leaks and suicides of students in Kota. The court emphasizes the need for a response from the NTA before making a decision. The NEET-UG exam, conducted on May 5 with around 24 lakh candidates, has faced allegations of irregularities, including question paper leaks, leading to protests and demands for investigation. The Centre and NTA have revoked grace marks for some candidates and offered them the option to retake the exam or relinquish the compensatory marks. The NEET-UG exam, organized by the NTA, is a nationwide test for admissions to various medical courses in India.
The Supreme Court Today (May 7th) questioned the Central government’s directive to AYUSH authorities, asking why they were instructed not to act against misleading advertisements under Rule 170 of the Drugs and Cosmetics Rules, 1945. The inquiry came during a hearing of a plea filed by the Indian Medical Association (IMA) against an alleged smear campaign by Patanjali Ayurved and its founders Baba Ramdev and Acharya Balkrishna, targeting the COVID-19 vaccination drive and modern medicine.
